American Capital Management Inc. Has $13.30 Million Stock Holdings in Cognex Corporation $CGNX

American Capital Management Inc. trimmed its holdings in Cognex Corporation (NASDAQ:CGNX) by 25.5% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 271,533 shares of the scientific and technical instruments company’s stock after selling 92,840 shares during the period. American Capital Management Inc.’s holdings in Cognex were worth $13,302,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Cognex by 173,138.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock valued at $376,979,000 after purchasing an additional 10,471,400 shares in the last quarter. Norges Bank bought a new stake in Cognex in the fourth quarter worth $73,103,000. Alyeska Investment Group L.P. bought a new stake in Cognex in the fourth quarter worth $68,388,000. AQR Capital Management LLC increased its position in Cognex by 18,810.9% during the second quarter. AQR Capital Management LLC now owns 1,794,649 shares of the scientific and technical instruments company’s stock worth $56,657,000 after buying an additional 1,785,159 shares during the last quarter. Finally, Pictet Asset Management Holding SA increased its position in Cognex by 27.9% during the fourth quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company’s stock worth $252,360,000 after buying an additional 1,529,010 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

Insider Activity

In other news, VP Darren Marc Long sold 20,252 shares of the stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the completion of the sale, the vice president directly owned 3,990 shares of the company’s stock, valued at approximately $264,696.60. This represents a 83.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Laura Ann Macdonald sold 41,600 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $65.56, for a total transaction of $2,727,296.00. Following the completion of the sale, the vice president owned 5,258 shares in the company, valued at approximately $344,714.48. The trade was a 88.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 224,847 shares of company stock valued at $14,975,098. 1.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities research analysts recently weighed in on CGNX shares. Robert W. Baird set a $72.00 target price on Cognex in a report on Friday, May 8th. UBS Group set a $75.00 price target on Cognex in a report on Tuesday, May 26th. Zacks Research raised shares of Cognex from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 16th. Stephens boosted their price objective on shares of Cognex from $65.00 to $75.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Finally, Seaport Research Partners set a $75.00 price objective on shares of Cognex in a report on Tuesday, May 26th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, Cognex currently has a consensus rating of “Moderate Buy” and an average price target of $72.31.

Cognex Stock Performance

Cognex stock opened at $61.29 on Tuesday. The business’s 50-day simple moving average is $64.96 and its 200-day simple moving average is $55.62. The firm has a market capitalization of $10.20 billion, a PE ratio of 72.96 and a beta of 1.49. Cognex Corporation has a 52 week low of $33.45 and a 52 week high of $72.88.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The business had revenue of $268.44 million during the quarter, compared to analysts’ expectations of $245.98 million. During the same quarter in the previous year, the firm earned $0.14 EPS. The firm’s revenue was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Research analysts forecast that Cognex Corporation will post 1.48 earnings per share for the current year.

Cognex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were issued a dividend of $0.085 per share. The ex-dividend date was Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.6%. Cognex’s payout ratio is 40.48%.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.